Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 194

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out

Open access
Neumann, Hartmut P.H., Erlic, Zoran, Boedeker, Carsten C., Rybicki, Lisa A., Robledo, Mercedes, Hermsen, Mario, Schiavi, Francesca, Falcioni, Maurizio, Kwok, Pingling, Bauters, Catherine, Lampe, Karen, Fischer, Markus, Edelman, Emily, Benn, Diana E., Robinson, Bruce G., Wiegand, Stefanie, Rasp, Gerd, Stuck, Boris A., Hoffmann, Michael M., Sullivan, Maren, Sevilla, Maria A., Weiss, Marjan M., Peczkowska, Mariola, Kubaszek, Agata, Pigny, Pascal, Ward, Robyn L., Learoyd, Diana, Croxson, Michael, Zabolotny, Dmitry, Yaremchuk, Svetlana, Draf, Wolfgang, Muresan, Mihaela, Lorenz, Robert R., Knipping, Stephan, Strohm, Michael, Dyckhoff, Gerhard, Matthias, Christoph, Reisch, Nicole, Preuss, Simon F., Eβer, Dirk, Walter, Martin A., Kaftan, Holger, Stöver, Timo, Fottner, Christian, Gorgulla, Harald, Malekpour, Mahdi, Zarandy, Masoud Motasaddi, Schipper, Jörg, Brase, Christoph, Glien, Alexander, Kühnemund, Matthias, Koscielny, Sven, Schwerdtfeger, Peter, Välimäki, Matti, Szyfter, Witold, Finckh, Ulrich, Zerres, Klaus, Cascon, Alberto, Opocher, Giuseppe, Ridder, Gerd J., Januszewicz, Andrzej, Suarez, Carlos, Eng, Charis · 2009 · Cancer Research

Abstract

Multiple genes and their variants that lend susceptibility to many diseases will play a major role in clinical routine. Genetics-based cost reduction strategies in diagnostic processes are important in the setting of multiple susceptibility genes for a single disease. Head and neck paraganglioma (HNP) is caused by germline mutations of at least three succinate dehydrogenase subunit genes (SDHx). Mutation analysis for all 3 costs ∼US$2,700 per patient. Genetic classification is essential for downstream management of the patient and preemptive management of family members. Utilizing HNP as a model, we wanted to determine predictors to prioritize the most heritable clinical presentations and which gene to begin testing in HNP presentations, to reduce costs of genetic screening. Patients were tested for SDHB, SDHC, and SDHD intragenic mutations and large deletions. Clinical parameters were analyzed as potential predictors for finding germline mutations. Cost reduction was calculated between prioritized gene testing compared with that for all genes. Of 598 patients, 30.6% had SDHx germline mutations: 34.4% in SDHB, 14.2% SDHC, and 51.4% SDHD. Predictors for an SDHx mutation are family history [odds ratio (OR), 37.9], previous pheochromocytoma (OR, 10.9), multiple HNP (OR, 10.6), age ≤40 years (OR, 4.0), and male gender (OR, 3.5). By screening only preselected cases and a stepwise approach, 60% cost reduction can be achieved, with 91.8% sensitivity and 94.5% negative predictive value. Our data give evidence that clinical parameters can predict for mutation and help prioritize gene testing to reduce costs in HNP. Such strategy is cost-saving in the practice of genetics-based personalized health care. [Cancer Res 2009;69(8):3650–6]

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-08-4057

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 194

Metadata

Authors
Neumann, H. P. H., Erlic, Z., Boedeker, C. C., Rybicki, L. A., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Bauters, C., Lampe, K., Fischer, M., Edelman, E., Benn, D. E., Robinson, B. G., Wiegand, S., Rasp, G., Stuck, B. A., Hoffmann, M. M., Sullivan, M., Sevilla, M. A., Weiss, M. M., Peczkowska, M., Kubaszek, A., Pigny, P., Ward, R. L., Learoyd, D., Croxson, M., Zabolotny, D., Yaremchuk, S., Draf, W., Muresan, M., Lorenz, R. R., Knipping, S., Strohm, M., Dyckhoff, G., Matthias, C., Reisch, N., Preuss, S. F., Eβer, D., Walter, M. A., Kaftan, H., Stöver, T., Fottner, C., Gorgulla, H., Malekpour, M., Zarandy, M. M., Schipper, J., Brase, C., Glien, A., Kühnemund, M., Koscielny, S., Schwerdtfeger, P., Välimäki, M., Szyfter, W., Finckh, U., Zerres, K., Cascon, A., Opocher, G., Ridder, G. J., Januszewicz, A., Suarez, C., & Eng, C.
Venue
Cancer Research
Published
2009-04-15
Volume
69
Issue
8
Pages
3650-3656
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2158885287
Cited by
194
References
6
FWCI
14.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out. https://app.cochat.ai/papers/10.1158/0008-5472.can-08-4057
The paper
Neumann, H. P. H., Erlic, Z., Boedeker, C. C., Rybicki, L. A., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Bauters, C., Lampe, K., Fischer, M., Edelman, E., Benn, D. E., Robinson, B. G., Wiegand, S., Rasp, G., Stuck, B. A., Hoffmann, M. M., . . . Eng, C. (2009). Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out. Cancer Research. https://doi.org/10.1158/0008-5472.can-08-4057

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.